A novel approach for production of an active N-terminally truncated Ulp1 (SUMO protease 1) catalytic domain from Escherichia coli inclusion bodies

被引:10
|
作者
Linova, Marina Y. [1 ]
Risor, Michael W. [2 ,5 ]
Jorgensen, Sanne E. [1 ]
Mansour, Zohra [1 ,3 ]
Kaya, Jacob [1 ,4 ]
Sigurdarson, Jens J. [1 ]
Enghild, Jan J. [2 ]
Karring, Henrik [1 ]
机构
[1] Univ Southern Denmark, Dept Chem Engn Biotechnol & Environm Technol, Campusvej 55, DK-5230 Odense M, Denmark
[2] Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark
[3] Novo Nordisk Pharmatech AS, Kobenhavnsvej 216, DK-4600 Koge, Denmark
[4] Chr Hansen AS, Boege Alle 10, DK-2970 Horsholm, Denmark
[5] BASF Enzymes LLC, 3550 John Hopkins Court, San Diego, CA 92121 USA
关键词
Ubiquitin-like protease (Ulp); Small ubiquitin-like modifier (SUMO); SUMO-Specific protease; Inclusion bodies; Refolding; L-arginine; SOLUBLE-PROTEIN; FUSION; EXPRESSION;
D O I
10.1016/j.pep.2019.105507
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The SUMO fusion system is widely used to facilitate recombinant expression and production of difficult-to express proteins. After purification of the recombinant fusion protein, removal of the SUMO-tag is accomplished by the yeast cysteine protease, SUMO protease 1 (Ulp1), which specifically recognizes the tertiary fold of the SUMO domain. At present, the expression of the catalytic domain, residues 403-621, is used for obtaining soluble and biologically active Ulp1. However, we have observed that the soluble and catalytically active Ulp1(403-621) inhibits the growth of E. coli host cells. In the current study, we demonstrate an alternative route for producing active Ulp1 catalytic domain from a His-tagged N-terminally truncated variant, residues 416-621, which is expressed in E. coli inclusion bodies and subsequently refolded. Expressing the insoluble Ulp1(416-621) variant is advantageous for achieving higher production yields. Approximately 285 mg of recombinant Ulp1(416-621) was recovered from inclusion bodies isolated from 1 L of high cell-density E. coli batch fermentation culture. After Ni2+-affinity purification of inactive and denatured Ulp1(416-621) in 7.5 M urea, different refolding conditions with varying L-arginine concentration, pH, and temperature were tested. We have successfully refolded the enzyme in 0.25 M L-arginine and 0.5 M Tris-HCl (pH 7) at room temperature. Approximately 80 mg of active Ulp1(415-621) catalytic domain can be produced from 1 L of high cell-density E. coli culture. We discuss the applicability of inclusion body-directed expression and considerations for obtaining high expression yields and efficient refolding conditions to reconstitute the active protein fold.
引用
收藏
页数:8
相关论文
共 15 条
  • [1] Robust production of active Ulp1 (SUMO protease) from inclusion bodies
    Patakottu, Bala Kota Reddy
    Vedire, Vikram Reddy
    Reddy, Chereddy Ramamohan
    PROTEIN EXPRESSION AND PURIFICATION, 2023, 211
  • [2] Expression, purification and renaturation of truncated human integrin β1 from inclusion bodies of Escherichia coli
    Shi, Lin
    Zhang, Lichao
    Li, Zhuoyu
    Newton, Ian P.
    Zhang, Quanbin
    PROTEIN EXPRESSION AND PURIFICATION, 2015, 107 : 13 - 19
  • [3] Bioprocess optimization for the overproduction of catalytic domain of ubiquitin-like protease 1 (Ulp1) from S-cerevisiae in E-coil fed-batch culture
    Adivitiya, Babbal
    Mohanty, Shilpa
    Khasa, Yogender Pal
    ENZYME AND MICROBIAL TECHNOLOGY, 2019, 120 : 98 - 109
  • [4] Expression and purification of biologically active recombinant human paraoxonase 1 from inclusion bodies of Escherichia coli
    Bajaj, Priyanka
    Tripathy, Rajan K.
    Aggarwal, Geetika
    Pande, Abhay H.
    PROTEIN EXPRESSION AND PURIFICATION, 2015, 115 : 95 - 101
  • [5] PREPARATION OF ACTIVE RECOMBINANT TIMP-1 FROM ESCHERICHIA-COLI INCLUSION-BODIES AND COMPLEX-FORMATION WITH THE RECOMBINANT CATALYTIC DOMAIN OF PMNL-COLLAGENASE
    KLEINE, T
    BARTSCH, S
    BLASER, J
    SCHNIERER, S
    TRIEBEL, S
    VALENTIN, M
    GOTE, T
    TSCHESCHE, H
    BIOCHEMISTRY, 1993, 32 (51) : 14125 - 14131
  • [6] LARGE-SCALE PURIFICATION AND REFOLDING OF HIV-1 PROTEASE FROM ESCHERICHIA-COLI INCLUSION-BODIES
    HUI, JO
    TOMASSELLI, AG
    REARDON, IM
    LULL, JM
    BRUNNER, DP
    TOMICH, CSC
    HEINRIKSON, RL
    JOURNAL OF PROTEIN CHEMISTRY, 1993, 12 (03): : 323 - 327
  • [7] The production of human papillomavirus type 16 L1 vaccine product from Escherichia coli inclusion bodies
    Lai, WB
    Middelberg, APJ
    BIOPROCESS AND BIOSYSTEMS ENGINEERING, 2002, 25 (02) : 121 - 128
  • [8] The production of human papillomavirus type 16 L1 vaccine product from Escherichia coli inclusion bodies
    W. Lai
    A. Middelberg
    Bioprocess and Biosystems Engineering, 2002, 25 : 121 - 128
  • [9] The N-Terminally Truncated μ3 and μ3-Like Opioid Receptors Are Transcribed from a Novel Promoter Upstream of Exon 2 in the Human OPRM1 Gene
    Andersen, Sonja
    Baar, Cecilie
    Fladvad, Torill
    Laugsand, Eivor Alette
    Skorpen, Frank
    PLOS ONE, 2013, 8 (08):
  • [10] Catalytically active inclusion bodies of L-lysine decarboxylase from E. coli for 1,5-diaminopentane production
    Kloss, Ramona
    Limberg, Michael H.
    Mackfeld, Ursula
    Hahn, Doris
    Grunberger, Alexander
    Jaeger, Vera D.
    Krauss, Ulrich
    Oldiges, Marco
    Pohl, Martina
    SCIENTIFIC REPORTS, 2018, 8